About

Julphar is one of the largest pharmaceutical manufacturers and distributors in the Middle East and North Africa (MENA) region.

With twelve state-of-the-art and ISO certified manufacturing facilities, Julphar currently holds 3,646 registration certificates for its products. The organization’s mission is to offer high quality medicines at competitive prices, whilst working towards positioning Ras Al Khaimah as a robust and growing market with a diversified economic base.

Well positioned to meet tomorrow’s healthcare challenges, Julphar maintains a diverse product portfolio which targets major therapeutic segments including endocrinology, anti-infective, cardiovascular and gastroenterology, over-the-counter, nephrology, dermatology, respiratory, metabolic and burn and wound management.

In line with its objective to promote better diabetes management in the region, Julphar is now the only company in the Middle East to produce the raw material needed to make insulin through its division dedicated to Diabetes.

Julphar employs approximately 3000 personnel around the world and the company reported year-end sales of approximately AED 1.44 billion in 2014.